Lexicon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1997
Revenue	2.31	1.2	0.14	0.3	24	322.07	Upgrade
Revenue Growth (YoY)	1734.13%	766.19%	-53.36%	-98.76%	-92.55%	409.54%	Upgrade
Cost of Revenue	0.12	0.09	0	0	1.93	3.23	Upgrade
Gross Profit	2.2	1.12	0.14	0.3	22.07	318.84	Upgrade
Selling, General & Admin	126.9	113.98	48.08	32.34	47.23	56.84	Upgrade
Research & Development	61.23	58.89	52.82	55.05	153.62	91.92	Upgrade
Other Operating Expenses	0	0	0	0	-130.99	28.64	Upgrade
Operating Expenses	188.14	172.87	100.9	87.39	69.87	177.4	Upgrade
Operating Income	-185.94	-171.75	-100.76	-87.09	-47.8	141.45	Upgrade
Interest Expense / Income	16.23	13.1	2.78	0.8	14.54	20.68	Upgrade
Other Expense / Income	-8.59	-7.73	-1.6	-0.13	-3.77	-3.35	Upgrade
Pretax Income	-193.58	-177.12	-101.94	-87.76	-58.57	124.12	Upgrade
Income Tax	0	0	0	0	0	-6.01	Upgrade
Net Income	-193.58	-177.12	-101.94	-87.76	-58.57	130.13	Upgrade
Shares Outstanding (Basic)	245	221	166	146	111	106	Upgrade
Shares Outstanding (Diluted)	245	221	166	146	111	117	Upgrade
Shares Change	29.83%	33.43%	13.79%	31.41%	-5.06%	10.32%	Upgrade
EPS (Basic)	-0.83	-0.80	-0.62	-0.60	-0.53	1.23	Upgrade
EPS (Diluted)	-0.83	-0.80	-0.62	-0.60	-0.53	1.16	Upgrade
Free Cash Flow	-185.64	-162.37	-90.18	-88.24	-132.04	113.74	Upgrade
Free Cash Flow Per Share	-0.76	-0.73	-0.54	-0.61	-1.19	1.07	Upgrade
Gross Margin	94.98%	92.94%	100.00%	100.00%	91.96%	99.00%	Upgrade
Operating Margin	-8045.91%	-14264.95%	-72489.21%	-29224.83%	-199.21%	43.92%	Upgrade
Profit Margin	-8376.55%	-14710.88%	-73341.01%	-29448.99%	-244.11%	40.40%	Upgrade
Free Cash Flow Margin	-8032.71%	-13485.63%	-64875.54%	-29610.07%	-550.29%	35.31%	Upgrade
Effective Tax Rate	-	-	-	-	-	-4.85%	Upgrade
EBITDA	-176.77	-163.46	-98.74	-86.66	-41.1	148.45	Upgrade
EBITDA Margin	-7648.98%	-13576.74%	-71033.81%	-29081.88%	-171.27%	46.09%	Upgrade
Depreciation & Amortization	0.59	0.55	0.43	0.29	2.93	3.65	Upgrade
EBIT	-177.35	-164.02	-99.16	-86.96	-44.03	144.8	Upgrade
EBIT Margin	-7674.34%	-13622.76%	-71341.01%	-29179.87%	-183.50%	44.96%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).